In EGFR‐mutant NSCLC, exosomal miRNAs (e.g., miR‐21, miR‐214, and miR‐522‐3p) contribute to the development of resistance to gefitinib.14, 15, 16. Here, EGFR is linked to non-small cell lung carcinoma.